380
glucagon is the most under-discussed thing in c/scamalerts
Something I noticed reading old threads that I have not seen said out loud. The advice on hepatic fat in this community changed substantially around the start of last…
u/marisol_frisk
Contributes reviews on supplier material. Based in Wrocław.
member · joined 14 May 2025
18,707post karma
10,795comment karma
9submissions
163comments
Overview — page 2 of 5
comment on small win: reimbursement stopped being a problem at week 85 in c/glp1eu · 5 points · 19 days ago
EU rules is usually a national question wearing a hat
comment on [Results] 42 weeks, 31kg, and dual agonist was the hard part in c/survodutide · 19 points · 19 days ago
Strongly agree. The safety story is separate.
comment on 24 months in and insulin syringe is still the thing I get wrong in c/reconstitution · 81 points · 23 days ago
Disagree. What you are describing is consistent with bacteriostatic water, not with what you concluded.
comment on 24 months in and insulin syringe is still the thing I get wrong in c/reconstitution · -27 points · 23 days ago
Are you using a u-100 or u-40 syringe? That changes everything.
comment on anyone else notice research peptides kicking in around week 9 in c/researchpeptides · 9 points · 1 months ago
not approved for human use, full stop
comment on identity and quantity are two questions and most COAs answer one in c/coa · 39 points · 1 months ago
Cosigning. The batch number is load-bearing information.
comment on [Question] how do you actually verify glucagon in c/survodutide · 27 points · 1 months ago
the safety profile is not just tirzepatide amplified
comment on bacteriostatic water is the most under-discussed thing in c/cagrilintide in c/reconstitution · 0 points · 1 months ago
controversial sort brought me here and it was worth it
comment on [Failure] two years in, stopped for financial reasons, regained most of it in c/darkspot · 10 points · 1 months ago
Small correction: the trial was 5 weeks, not 38. Does not change your point but people will quote it.
comment on glucagon is the most under-discussed thing in c/scamalerts in c/survodutide · 16 points · 1 months ago
Stalled for 16 weeks, changed nothing, and it started moving again on week 73.
comment on glucagon is the most under-discussed thing in c/scamalerts in c/survodutide · 18 points · 1 months ago
MASH claims need the trial and the biopsy endpoint
comment on glucagon is the most under-discussed thing in c/scamalerts in c/survodutide · 21 points · 1 months ago
The confident tone is doing a lot of work that the evidence is not.
comment on switched from 2.4mg to 1.7mg and the reflux got better, not worse in c/glp1eu · 1 points · 1 months ago
Strongly agree. Pricing is local.
comment on lowest effective dose: the version I wish someone had shown me in week 1 in c/maintenancephase · 6 points · 2 months ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on what would you tell week-1 you about HPLC in c/hplc · 159 points · 2 months ago
This is the correct method framing. Column and gradient are load-bearing fields.
comment on dead space vs reconstitution — genuinely asking which matters more in c/reconstitution · 43 points · 2 months ago
This is correct. 3mL versus 8mL is the common mistake.
comment on is it normal to get the food-noise thing at week 40 in c/coa · 8 points · 2 months ago
post the whole document, not the headline number
comment on unpopular opinion: mg/mL is massively overrated in c/reconstitution · 352 points · 2 months ago
swirl, do not shake, or you are courting oxidation
comment on unpopular opinion: purity is massively overrated in c/hplc · 7 points · 2 months ago
axis labels included, always